Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Usage of Tranexamic Acid During Colonic Endoscopic Resection Procedures
NCT05345613Phase 4Recruiting
- Sponsor
- Shamir Medical Center
- Start
- May 2022
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in hemorrhage (2 arms), sponsored by Shamir Medical Center. Primary endpoint: Postprocedural bleeding. Started May 2022; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT05345613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05345613.